Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seaweed Sciences is a biotechnology company focused on the discovery and development of novel therapeutic compounds derived from marine seaweed. The company leverages a proprietary platform to identify and isolate bioactive molecules with potential applications in treating pain, inflammation, and metabolic diseases. By exploring the chemical diversity of seaweed, Seaweed Sciences aims to create a new class of sustainable, marine-based pharmaceuticals. Their research primarily targets the endocannabinoid system and other key metabolic pathways to address unmet medical needs. The company is currently in the pre-clinical stage, advancing several lead candidates through early-stage validation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seaweed Sciences.